Alzheimer's Disease/Cognition News

PHILADELPHIA — Safe and effective ways to introduce anti-amyloid medications for Alzheimer’s disease depends on comprehensive care infrastructure from screening to administration, according to a speaker.

Up to 25% of cancer survivors are affected by persistent symptoms of cognitive dysfunction.

Infection-specific processes, rather than general systemic inflammation, may play a role in the development of dementia among those with hospital-diagnosed infections, according to research from JAMA Network Open.

Analysis of the online conversation among health care professionals on social media in July revealed significant online discussion and support for the first-ever nonprescription daily oral contraceptive, norgestrel 0.075 mg.

Patients with post-incident dementia were more likely to begin central nervous system medications and less likely to discontinue cardiometabolic and anticholinergic medications, reflecting missed deprescribing opportunities, according to researchers.

A clinical-stage biopharmaceutical company has announced the submission of an investigational new drug application to the FDA based upon results of a phase 2a clinical study of a novel lithium delivery system, AL001, for bipolar disorder.

Long-term exposure to extreme heat can lead to cognitive decline, according to experts.

Artificial intelligence could help clinicians address the social needs of patients with dementia, according to Elham Mahmoudi, PhD.

A Boston-area clinical stage drug discovery and development company announced $6 million in pre-Series B bridge financing to advance a novel cerebroprotectant therapeutic intended to treat a broad range of acute brain injuries.

Greater residential levels of fine particulate matter air pollution, especially from agriculture and wildfires, were linked to higher rates of dementia, according to study results published in JAMA Internal Medicine.